Changing treatment patterns for hepatocellular carcinoma: A SEER-Medicare study.

被引：0
|
作者：
Iheanacho, Franklin
Tramontano, Angela
Abrams, Thomas Adam
Manz, Christopher
机构：
[1] Dana Farber Canc Inst, Div Populat Sci, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA USA
[3] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16166
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Surveillance Patterns and Survival in Hepatocellular Carcinoma: A Seer-medicare Analysis
    Papageorge, Marianna V.
    de Geus, Susanna W.
    Woods, Alison P.
    Ng, Sing Chau
    McAneny, David
    Tseng, Jennifer F.
    Kenzik, Kelly M.
    Sachs, Teviah E.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 391 - 391
  • [2] Comparative and Cost Effectiveness of Treatment Modalities for Hepatocellular Carcinoma in SEER-Medicare
    Shaya, Fadia T.
    Breunig, Ian M.
    Seal, Brian
    Mullins, C. Daniel
    Chirikov, Viktor V.
    Hanna, Nader
    [J]. PHARMACOECONOMICS, 2014, 32 (01) : 63 - 74
  • [3] Comparative and Cost Effectiveness of Treatment Modalities for Hepatocellular Carcinoma in SEER-Medicare
    Fadia T. Shaya
    Ian M. Breunig
    Brian Seal
    C. Daniel Mullins
    Viktor V. Chirikov
    Nader Hanna
    [J]. PharmacoEconomics, 2014, 32 : 63 - 74
  • [4] TREATMENT MODALITIES FOR HEPATOCELLULAR CARCINOMA: CUMULATIVE EXPENDITURES AND SURVIVAL IN SEER-MEDICARE
    Shaya, F. T.
    Breunig, I. M.
    Seal, B.
    Mullins, C. D.
    Chirikov, V. V.
    Hanna, N. N.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A134 - A134
  • [5] Patterns of care and outcomes in carcinoma of unknown primary: A SEER-Medicare study
    Mileshkin, L.
    Bochtler, T.
    Beringer, A.
    Mueller-Ohldach, M.
    Surinach, A.
    Perret, C.
    Thomas, M.
    Gondos, A.
    Kraemer, A.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S459 - S459
  • [6] Hepatocellular Carcinoma Survival by Etiology: A SEER-Medicare Database Analysis
    Brar, Gagandeep
    Greten, Tim F.
    Graubard, Barry, I
    McNeel, Timothy S.
    Petrick, Jessica L.
    McGlynn, Katherine A.
    Altekruse, Sean F.
    [J]. HEPATOLOGY COMMUNICATIONS, 2020, 4 (10) : 1541 - 1551
  • [7] Multispecialty care among hepatocellular carcinoma patients in SEER-Medicare
    Breunig, Ian Michael
    Shaya, Fadia T.
    Mullins, C. Daniel
    Chirikov, Viktor
    Seal, Brian S.
    Hanna, Nader
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Cost-effectiveness analysis of treatment modalities for hepatocellular carcinoma in the SEER-Medicare population
    Hanna, Nader
    Shaya, Fadia T.
    Breunig, Ian Michael
    Chirikov, Viktor
    Seal, Brian S.
    Mullins, C. Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Adoption of hypofractionated radiotherapy (HyRT) for ductal carcinoma in situ (DCIS): A SEER-Medicare study.
    Falchook, Aaron David
    Hendrix, Laura H.
    VanderWalde, Noam Avraham
    Zagar, Timothy M.
    Jones, Ellen
    Jagsi, Reshma
    Chen, Ronald C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Geographic Variations of Potentially Curative Treatments for Hepatocellular Carcinoma in the United States: A SEER-Medicare Study
    Cheng, En
    Hung, Peiyin
    Wang, Shi-Yi
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (06): : 729 - +
12345